Carcinoma skin in association with Chronic Myeloid Leukemia; a case report
Keywords:cml, hydroxy-urea, skin cancer
Hydroxyurea (HU) is a cytostatic agent used to treat myeloproliferative disorders including chronic myeloid leukemia (CML), the long term use of which has been seen to be associated with multiple skin disorders. The purpose of this study was to report concomitant occurrence of multiple skin carcinomas in patients on HU & consider an alternative chemotherapeutic agent for myeloproliferative disorders.
Bangladesh Journal of Medical Science Vol.16(3) 2017 p.464-466
How to Cite
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.